Ayden Court Nursing And Rehabilitation Center in Ayden, NC

Ayden Court Nursing And Rehabilitation Center is a medicare and medicaid certified nursing home in Ayden, North Carolina. It is located in Pitt county at 128 Snow Hill Road, Ayden, North Carolina 28513. You can reach out to the office of Ayden Court Nursing And Rehabilitation Center via phone at (252) 746-8223. This skilled nursing facility has 82 federally certified beds with average occupancy rate of 85.49%. Its legal business name is River Neuse Group, Llc and has the following ownership type - For Profit - Corporation.

Ayden Court Nursing And Rehabilitation Center (Medicare CCN 345490) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1999 (25 years certified) and the last quality survey was conducted in March, 2021.

Contact Information

Ayden Court Nursing And Rehabilitation Center
128 Snow Hill Road, Ayden, North Carolina 28513
(252) 746-8223


Nursing Home Profile

NameAyden Court Nursing And Rehabilitation Center
Location128 Snow Hill Road, Ayden, North Carolina
Certified ByMedicare and Medicaid
No. of Certified Beds82
Occupancy Rate85.49%
Medicare ID (CCN)345490
Legal Business NameRiver Neuse Group, Llc
Ownership TypeFor Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Ayden Court Nursing And Rehabilitation Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1245491265
Organization NamePEOPLEFIRST REHAB
Address128 Snow Hill St, Ayden, NC 28513
Phone Number252-746-8223

News Archive

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

Food Safety News releases 2009 "Naughty" list, "Nice" list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging "Naughty" list will be followed by a kudos-to "Nice" list, just in time for Santa's sleigh.

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Read more Medical News

› Verified 5 days ago


NPI Number1295993681
Organization NamePEOPLEFIRST REHAB
Address128 Snow Hill St, Ayden, NC 28513
Phone Number252-746-8223

News Archive

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

Food Safety News releases 2009 "Naughty" list, "Nice" list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging "Naughty" list will be followed by a kudos-to "Nice" list, just in time for Santa's sleigh.

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Read more Medical News

› Verified 5 days ago


NPI Number1356372650
Organization NameRIVER NEUSE GROUP, LLC
Doing Business AsAYDEN COURT NURSING AND REHABILITATION CENTER.
Address128 Snow Hill St, Ayden, NC 28513
Phone Number252-746-8223

News Archive

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

Food Safety News releases 2009 "Naughty" list, "Nice" list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging "Naughty" list will be followed by a kudos-to "Nice" list, just in time for Santa's sleigh.

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Read more Medical News

› Verified 5 days ago


NPI Number1811154636
Organization NamePEOPLEFIRST REHAB
Address128 Snow Hill St, Ayden, NC 28513
Phone Number252-746-8223

News Archive

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

Food Safety News releases 2009 "Naughty" list, "Nice" list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging "Naughty" list will be followed by a kudos-to "Nice" list, just in time for Santa's sleigh.

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Read more Medical News

› Verified 5 days ago


NPI Number1932367323
Organization NamePEOPLEFIRST REHAB
Address128 Snow Hill St, Ayden, NC 28513
Phone Number252-746-8223

News Archive

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

Food Safety News releases 2009 "Naughty" list, "Nice" list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging "Naughty" list will be followed by a kudos-to "Nice" list, just in time for Santa's sleigh.

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Read more Medical News

› Verified 5 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Ayden Court Nursing And Rehabilitation Center are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Ayden Court Nursing And Rehabilitation Center give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

Food Safety News releases 2009 "Naughty" list, "Nice" list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging "Naughty" list will be followed by a kudos-to "Nice" list, just in time for Santa's sleigh.

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Read more Medical News

› Verified 5 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines3
Total Amount of Fines in Dollars$33113
Number of Payment Denials0
Total Number of Penalties3

Patients' Stay Experience:

The resident survey data of Ayden Court Nursing And Rehabilitation Center is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased20.7314.46
Percentage of long-stay residents who lose too much weight13.115.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder34.7848.41
Percentage of long-stay residents with a catheter inserted and left in their bladder1.891.79
Percentage of long-stay residents with a urinary tract infection1.92.65
Percentage of long-stay residents who have depressive symptoms05.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury0.883.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine10093.87
Percentage of long-stay residents who received an antipsychotic medication0.9314.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine97.6483.88
Percentage of short-stay residents who newly received an antipsychotic medication01.79
Percentage of long-stay residents whose ability to move independently worsened55.2117.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication21.6219.7
Percentage of high risk long-stay residents with pressure ulcers4.17.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine10095.98
Percentage of short-stay residents who made improvements in function58.3967.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine96.0382.93

News Archive

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

Food Safety News releases 2009 "Naughty" list, "Nice" list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging "Naughty" list will be followed by a kudos-to "Nice" list, just in time for Santa's sleigh.

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Read more News

› Verified 5 days ago


Nursing Homes in Ayden, NC

Ayden Court Nursing And Rehabilitation Center
Location: 128 Snow Hill Road, Ayden, North Carolina 28513
Phone: (252) 746-8223    

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.